Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
Eur Rev Med Pharmacol Sci ; 28(3): 1202-1212, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38375725

ABSTRACT

OBJECTIVE: Standard phytochemical investigations were performed to identify the secondary metabolites in the methanol extract of Chaetocarpus castanocarpus bark (MECC) and investigate the neuropharmacological potential of MECC in Swiss albino mice. MATERIALS AND METHODS: Swiss albino mice were used in the forced swimming test (FST) and tail suspension test (TST) to evaluate the antidepressant effect of MECC. Also, the hole board test (HBT) and elevated plus maze (EPM) were conducted to examine anxiolytic activities. In contrast, the open field test (OFT) and hole cross test (HCT) were employed to evaluate sleeping disorders. RESULTS: Alkaloids, glycosides, flavonoids, terpenoids, coumarins, and tannins are only a few secondary metabolites identified in MECC by qualitative and quantitative phytochemical investigations. The oral administration of MECC considerably shortened the immobility duration during FST and TST. Encouraging dose-dependent anxiolytic effects were also observed in all relevant experiments compared to the control. Additionally, during the OFT and HCT assessment, a noteworthy decline in the locomotor activities of the experimental animals was observed. CONCLUSIONS: The results of this investigation suggest that the Chaetocarpus castanocarpus bark is a possible source of therapeutic candidates for treating neurological disorders.


Subject(s)
Anti-Anxiety Agents , Mice , Animals , Anti-Anxiety Agents/pharmacology , Anti-Anxiety Agents/therapeutic use , Hypnotics and Sedatives/pharmacology , Plant Bark , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Behavior, Animal , Antidepressive Agents/pharmacology , Antidepressive Agents/therapeutic use , Methanol/pharmacology , Phytochemicals/pharmacology
2.
Arch Razi Inst ; 77(2): 881-890, 2022 Apr.
Article in English | MEDLINE | ID: mdl-36284956

ABSTRACT

The current study aimed to investigate the neuropharmacological properties of ethanol, acetone, and ethyl acetate leaf extracts of Chassalia curviflora (C. curviflora) in mouse models. The neuropharmacological properties of this plant were studied on Swiss albino mice at dosages of 50, 100, and 200 mg/kg body weight in thiopental sodium-induced sleeping time test, and at dosages of 100 and 200 mg/kg body weight in other tests. The extracts caused a marked reduction in the initiation and sleep length (P<0.05) in studies on thiopental sodium-induced sleeping time at dosages of 100 and 200 mg/kg and a significant decrease (P<0.05) was found in terms of unconstrained locomotor and explorative activities in both hole crossing and open field tests at dosages of 100 and 200 mg/kg. Furthermore, the extracts increased sleeping time with a dosage-dependent onset of action. The hole-board test extracts also reduced the number of head dips at dosages of 100 and 200 mg/kg (P<0.05). It was found in this study that C. curviflora had the best neuropharmacological properties at a dosage of 200 ml/kg. Our findings also showed that all of the extracts from C. curviflora were experimentally active in an in vivo model. The study results suggested that the leaves had strong anti-depressant and hypnotic CNS properties that might be exploited for neuropharmacological adjuvant therapy in conventional medicine. However, pharmacological studies are warranted to explore the active substances and the mode of action.


Subject(s)
Rubiaceae , Mice , Animals , Plant Extracts/pharmacology , Thiopental/pharmacology , Acetone/pharmacology , Behavior, Animal , Hypnotics and Sedatives/pharmacology , Ethanol/pharmacology , Body Weight
3.
J Back Musculoskelet Rehabil ; 32(1): 55-62, 2019.
Article in English | MEDLINE | ID: mdl-30149440

ABSTRACT

OBJECTIVE: This study compared the effectiveness of regenerative injection therapy (RIT), i.e. prolotherapy, and repetitive transcranial magnetic stimulation (rTMS) in the treatment of fibromyalgia syndrome. PATIENTS AND METHODS: This study included 120 female, age-matched fibromyalgia patients. All patients underwent a clinical examination, pain assessment by VAS, assessment of tender points, psychiatric and functional assessment using the Beck Depression Inventory (BDI), Fibromyalgia Impact Questionnaire Revised (RFIQ), and measurement of cortical auditory evoked potentials CAEPs elicited at 1000 Hz. Patients were divided into two equal groups; Group 1 received prolotherapy three times, two weeks apart, and Group 2 received rTMS sessions every other day for one month. Assessment was performed before treatment, immediately after treatment, and one month later. RESULTS: A significant improvement of pain measured by the mean score of VAS was remarked in Group 1 compared to Group 2 immediately after treatment and one month later. There was statistically significant difference of mean scores for the number of tender points in Group 1 compared to Group 2 after treatment and one month later. The patients improved functionally, with a statistically significant difference in mean score of RFIQ, in Group 1 compared to Group 2 one month after treatment. However, there was a significant difference in mean score of BDI in Group 2 compared to Group 1 after treatment and one month later. Further, CAEPs showed better improvement, with a significant difference in Group 2, one month after treatment. CONCLUSION: RIT had the advantage in clinical and functional improvement in fibromyalgia patients, while rTMS had better results regarding depression and the cortical component of AEPs. These results might draw attention to the evaluability of a combination of both techniques for a better therapeutic response.


Subject(s)
Fibromyalgia/therapy , Prolotherapy/statistics & numerical data , Transcranial Magnetic Stimulation/statistics & numerical data , Depression/therapy , Female , Fibromyalgia/psychology , Humans , Pain/etiology , Pain Management/methods , Pain Measurement , Treatment Outcome
4.
Neuroscience ; 210: 340-52, 2012 May 17.
Article in English | MEDLINE | ID: mdl-22441036

ABSTRACT

The objective of the present study was to assess the neuroprotective role of rutin (vitamin P) and delineate the mechanism of action. Recent evidence indicates that rutin exhibits antioxidant potential and protects the brain against various oxidative stressors. More precisely, the aim of the present study was to examine the modulating impacts of rutin against cognitive deficits and oxidative damage in intracerebroventricular-streptozotocin (ICV-STZ)-infused rats. Rats were injected bilaterally with ICV-STZ (3 mg/kg), whereas sham rats received the same volume of vehicle. After 2 weeks of streptozotocin (STZ) infusion, rats were tested for cognitive performance using Morris water maze tasks and thereafter euthanized for further biochemical, histopathological, and immunohistochemical studies. Rutin pretreatment (25 mg/kg, orally, once daily for 3 weeks) significantly attenuated thiobarbituric acid reactive substances (TBARS), activity of poly ADP-ribosyl polymerase, and nitrite level and decreased level of reduced glutathione (GSH) and activities of its dependent enzymes (glutathione peroxidase [GPx] and glutathione reductase [GR]) and catalase in the hippocampus of ICV-STZ rats. ICV-STZ rats showed significant cognitive deficits, which was improved significantly by rutin supplementation. The results indicate that rutin attenuates STZ-induced inflammation by reducing the expression of cyclooxygenase-2 (COX-2), glial fibrillary acidic protein (GFAP), interleukin-8 (IL-8), inducible nitric oxide synthase (iNOS), nuclear factor-kB, and preventing the morphological changes in hippocampus. The study thereby suggests the effectiveness of rutin in preventing cognitive deficits and might be beneficial for the treatment of sporadic dementia of Alzheimer type (SDAT).


Subject(s)
Alzheimer Disease/metabolism , Antioxidants/pharmacology , Inflammation/metabolism , Oxidative Stress/drug effects , Rutin/pharmacology , Alzheimer Disease/drug therapy , Animals , Brain/drug effects , Brain/metabolism , Cognition Disorders/metabolism , Cognition Disorders/prevention & control , Disease Models, Animal , Fluorescent Antibody Technique , Immunohistochemistry , Male , Maze Learning/drug effects , Rats , Rats, Wistar
5.
Clin Endocrinol (Oxf) ; 71(6): 828-33, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19508593

ABSTRACT

OBJECTIVE: To investigate the role of serum osteoprotegerin (OPG) and OPG gene polymorphisms in relation to cardiovascular (CV) and all-cause mortality in elderly women. BACKGROUND: The OPG/RANK/RANKL plays a vital role in bone cell biology. It has also been detected in myocardial tissue and atherosclerotic plaques. In some population studies, OPG and OPG gene polymorphisms have been associated with CV disease risk. DESIGN, MEASUREMENTS AND RESULTS: In an 8.5-year cohort population study of 1333 postmenopausal women mean age 75.2 ± 2.7 years, serum OPG concentrations above the median were associated with an increased risk of all-cause [odds ratio (OR) 1.39 (1.04-1.85)], and in particular CV mortality [OR 1.83 (1.10-3.05)], before and after adjusting for age, BMI, treated hypertension, diabetes, hypercholesterolemia, previous HRT use, calcium supplementation and smoking. Genotyping the OPG gene did not provide further information on the association between OPG and CV risk or mortality events. CONCLUSIONS: Raised osteoprotegerin appears to be an independent risk factor for total and CV death and thus has potential as a useful biomarker of risk as well as a potential target for therapeutic intervention.


Subject(s)
Osteoprotegerin/blood , Osteoprotegerin/genetics , Polymorphism, Genetic/genetics , Aged , Cardiovascular Diseases/blood , Cardiovascular Diseases/genetics , Cardiovascular Diseases/mortality , Cohort Studies , Female , Humans , Risk Factors
6.
Phytother Res ; 23(2): 293-6, 2009 Feb.
Article in English | MEDLINE | ID: mdl-18853399

ABSTRACT

Mentha spicata Linn. (mint), a herb well known for its gastroprotective properties in the traditional system of medicine has been shown to protect against radiation-induced lethality, and recently its constituents have been found to possess calcium channel antagonizing properties. The present study examined the behavioral radioprotective efficacy of mint oil (obtained from Mentha spicata), particularly in mitigating radiation-induced conditioned taste aversion (CTA), which has been proposed as a behavioral endpoint that is mediated by the toxic effects of gamma radiation on peripheral systems, primarily the gastrointestinal system in the Sprague-Dawley rat model. Intraperitoneal administration of Mentha spicata oil 10% (v/v), 1 h before 2 Gy gamma radiation, was found to render significant radioprotection against CTA (p < 0.05), by blocking the saccharin avoidance response within 5 post-treatment observational days, with the highest saccharin intake being observed on day 5. This finding clearly demonstrates that gastroprotective and calcium channel antagonizing properties of Mentha spicata can be effectively utilized in preventing radiation-induced behavioral changes.


Subject(s)
Gamma Rays/adverse effects , Mentha/chemistry , Plant Oils/pharmacology , Radiation-Protective Agents/pharmacology , Taste/radiation effects , Animals , Avoidance Learning/drug effects , Conditioning, Psychological/drug effects , Male , Rats , Rats, Sprague-Dawley , Saccharin/pharmacology
7.
Indian J Exp Biol ; 46(1): 35-40, 2008 Jan.
Article in English | MEDLINE | ID: mdl-18697569

ABSTRACT

In the present study, cardioprotective effect of aqueous extract of fruits of Embelia ribes Burm (ER) was evaluated in a rat model having acute myocardial infarction, induced by isoproterenol (5.25 and 8.5 mg/kg, sc, for two consecutive days). Aqueous ER extract (100 mg/kg) pretreatment orally for 40 days in isoproterenol (ISO)-treated rats significantly decreased the heart rate, systolic blood pressure, increased levels of serum lactate dehydrogenase, serum creatine kinase and myocardial lipid peroxides and significantly increased the myocardial endogenous antioxidants (glutathione, superoxide dismutase and catalase) levels. The results of biochemical observations in serum and heart tissues were supplemented by histopathological examination of rat's heart sections to confirm the myocardial injury. The results were comparable to that of gliclazide treated group. The present results provide evidence for the first time, that aqueous ER extract pretreatment ameliorated myocardial injury and enhanced the antioxidant defense against ISO-induced myocardial infarction in rats and exhibited cardioprotective property.


Subject(s)
Isoproterenol/pharmacology , Myocardial Infarction/chemically induced , Myocardial Infarction/prevention & control , Myocardium/pathology , Plant Extracts/metabolism , Animals , Antioxidants/metabolism , Blood Pressure , Embelia/metabolism , Flavonoids/chemistry , Glutathione/metabolism , Hemodynamics , Lipids/chemistry , Models, Biological , Myocardial Infarction/metabolism , Phenols/chemistry , Polyphenols , Rats , Superoxides/metabolism
8.
Fundam Clin Pharmacol ; 22(3): 305-14, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18485149

ABSTRACT

Antioxidants have been the focus of studies for developing neuroprotective agents to be used in the therapy for stroke, which is an acute and progressive neurodegenerative disorder and is the second leading cause of death throughout the world. In fact, many herbal antioxidants have been developed in in vitro and in vivo experiments and some of these have been tested in clinical studies of stroke. Embelia ribes have been reported to have antioxidant and antidiabetic effects. In addition to these effects, this study was designed to investigate the neuroprotective effect of ethanolic extract of E. ribes Burm fruits on middle cerebral artery occlusion (MCAO)-induced focal cerebral ischemia in rats. Male Wistar albino rats were fed ethanolic E. ribes extract (100 and 200 mg/kg body weight; p.o.) for 30 days. After 30 days of feeding, all animals were anaesthetized with chloral hydrate (400 mg/kg, i.p.). The right middle cerebral artery was occluded with a 4-0 suture for 2 h. The suture was removed after 2 h to allow reperfusion injury. Ischemia followed by reperfusion in ischemic group rats significantly (P < 0.001) reduced the grip strength activity and non-enzymatic (reduced glutathione, GSH) and enzymatic [glutathione peroxidase (GPx), glutathione reductase (GR) and glutathione-S-transferase (GST)] antioxidant levels in hippocampus and frontal cortex compared to sham-operated rats. Further, serum lactate dehydrogenase (LDH) and thiobarbituric acid reactive substance (TBARS) levels in hippocampus and frontal cortex were significantly increased in ischemic group compared to sham-operated rats. Furthermore, ethanolic E. ribes extracts pretreatment significantly (P < 0.001) increased the grip strength activity, and GSH, GPx, GR and GST levels in hippocampus and frontal cortex with significant decrease in LDH levels in serum and TBARS levels in hippocampus and frontal cortex compared to MCAO + vehicle group rats. The data from this study suggest that chronic treatment with ethanolic E. ribes extract enhances the antioxidant defense against MCAO- induced focal cerebral ischemia in rats and exhibits neuroprotective activity.


Subject(s)
Antioxidants/therapeutic use , Embelia/chemistry , Ischemic Attack, Transient/prevention & control , Neuroprotective Agents/therapeutic use , Oxidative Stress/drug effects , Phytotherapy , Reperfusion Injury/prevention & control , Animals , Ethanol , Fruit , Glutathione/metabolism , Glutathione Peroxidase/metabolism , Glutathione Reductase/metabolism , Glutathione Transferase/metabolism , Hand Strength , Hippocampus/drug effects , Hippocampus/enzymology , Infarction, Middle Cerebral Artery/complications , Ischemic Attack, Transient/etiology , Ischemic Attack, Transient/metabolism , L-Lactate Dehydrogenase/metabolism , Male , Plant Extracts/therapeutic use , Rats , Rats, Wistar , Reperfusion Injury/metabolism , Reperfusion Injury/pathology , Thiobarbituric Acid Reactive Substances/metabolism
9.
Pharmacol Biochem Behav ; 84(2): 179-88, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16797061

ABSTRACT

At the organismic level, exposure to radiation can produce taste aversion (CTA) learning and emesis, which have been proposed as behavioral endpoints that are mediated by harmful effects of radiations on peripheral systems, primarily the gastrointestinal system. Thus, the aim of the present investigation was to study the gastroprotective action of hydroalcoholic extract of zingiber rhizome (Zingiber officinale Rosc.) against radiation-induced conditioned taste aversion (CTA) in both male and female species of animals, for testing its potential as a behavioral radioprotector. Administration of zingiber extract 1 h before 2-Gy gamma-radiation was significantly effective in blocking the saccharin avoidance response, with 200 and 250 mg/kg b.wt. i.p., being the most effective doses for male and female rats, respectively. A comparison of the efficacy of zingiber extract with two antiemetic drugs, ondansteron and dexamethasone, revealed that the extract rendered comparable protection against radiation-induced CTA. Our experiments also confirmed the existence of sex dichotomy (i.e., the sex of animal greatly influenced response towards radiation exposure) in relation to behavioral responses (CTA) or differential metabolism. The observed gender variations were hypothesized to be a result of hormonal fluctuations and differences in pharmacological parameters in male and female rats. To correlate the mechanism of action, the free-radical-scavenging potential of zingiber extract to scavenge hydroxyl ion and nitric oxide was also tested, in cell-free system and a concentration of 1000 microg/ml, was found to be the most potent, which has been proposed as one the many activities assisting in its overall ability to modulate radiation-induced taste aversion. The results demonstrate that Z. officinale possesses antioxidant, radioprotective and neuromodulatory properties that can be effectively utilized for behavioral radioprotection and for efficiently mitigating radiation-induced CTA in both males and females species.


Subject(s)
Conditioning, Psychological/radiation effects , Drinking Behavior/radiation effects , Taste/radiation effects , Zingiber officinale , Animals , Antiemetics/pharmacology , Conditioning, Psychological/drug effects , Dexamethasone/pharmacology , Drinking Behavior/drug effects , Female , Free Radical Scavengers/pharmacology , Gamma Rays , Male , Ondansetron/pharmacology , Plant Extracts/pharmacology , Radiation-Protective Agents/pharmacology , Rats , Rats, Sprague-Dawley , Saccharin , Taste/drug effects , Whole-Body Irradiation/adverse effects
10.
Pharmacol Biochem Behav ; 81(4): 864-70, 2005 Aug.
Article in English | MEDLINE | ID: mdl-16023187

ABSTRACT

The aim of the present study was to investigate the neurobehavioral protective efficacy of a hydroalcoholic extract of ginger (Zingiber officinale Rosc.) in mitigating gamma radiation-induced conditioned taste aversion in Sprague-Dawley rats. Administration of Zingiber extract 1 h before 2-Gy gamma irradiation was effective in blocking the saccharin avoidance response for 5 post-treatment observational days, both in a dose- and time-dependent manner, with 200 mg/kg b.w. i.p. being the most effective dose. Highest saccharin intake in all the groups was observed on the fifth post-treatment day. The potential of ginger extract to inhibit lipid peroxidation induced by radiation (2 Gy) and ascorbate-ion stress in brain homogenate and its ability to scavenge highly reactive superoxide anions were evaluated. The 1000-microg/ml and 2000-microg/ml concentration of ginger extract showed the highest efficiency in scavenging free radicals and in inhibiting lipid peroxidation. The lipid peroxidation and superoxide-anion scavenging ability of the extract further supports its radioprotective properties. The results clearly establish the neurobehavioral efficacy of ginger extract and the antioxidant properties appear to be a contributing factor in its overall ability to modulate radiation-induced conditioned taste aversion. Ginger extract has tremendous potential for clinical applications in mitigation of radiation-induced emesis in humans.


Subject(s)
Conditioning, Psychological/drug effects , Plant Extracts/pharmacology , Taste/drug effects , Zingiber officinale , Animals , Body Weight/drug effects , Body Weight/radiation effects , Brain/drug effects , Brain/metabolism , Brain/radiation effects , Conditioning, Psychological/radiation effects , Dose-Response Relationship, Drug , Drinking Behavior/drug effects , Drinking Behavior/radiation effects , Free Radical Scavengers/pharmacology , Gamma Rays , Lipid Peroxidation/drug effects , Lipid Peroxidation/radiation effects , Male , Malondialdehyde/metabolism , Plant Extracts/isolation & purification , Rats , Rats, Sprague-Dawley , Saccharin/administration & dosage , Taste/radiation effects , Thiobarbituric Acid Reactive Substances/metabolism , Time Factors
12.
Biol Trace Elem Res ; 77(3): 251-9, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11204467

ABSTRACT

The effect of sodium selenite (0.05, 0.1, and 0.2 mg/kg body weight, i.p.) on the lipid levels (total lipids, phospholipids, cholesterol, gangliosides), thiobarbituric acid reactive substance (TBARS), and sulfhydryl group (-SH) in the striatum and thalamus of a male Wistar rat was studied after 7 d of treatment. The level of total lipids and cholesterol was significantly and dose-dependently elevated in the striatum and thalamus with 0.1 and 0.2 mg/kg of sodium selenite. However, the cholesterol level was significantly increased only with 0.2 mg/kg of sodium selenite in the thalamus. The level of phospholipids and gangliosides was more significant with 0.1 mg/kg of sodium selenite as compared to 0.2 mg. No significant alteration on the gangliosides level was observed in the thalamus with various doses of sodium selenite although the elevation with 0.2 mg dose was 25.9%. The content of TBARS was elevated dose dependently in striatum, but its level was depleted significantly with 0.1-mg/kg dose of sodium selenite in the thalamus. The level of the -SH group was significantly depleted in the striatum with 0.1-mg/kg dose of sodium selenite; conversely, this dose has significantly elevated the levels of -SH group in the thalamus.


Subject(s)
Corpus Striatum/metabolism , Lipid Metabolism , Lipid Peroxidation/drug effects , Selenium/therapeutic use , Sulfhydryl Compounds/metabolism , Thalamus/metabolism , Animals , Dose-Response Relationship, Drug , Male , Oxidative Stress , Rats , Rats, Wistar , Sodium Selenite/pharmacology , Thiobarbituric Acid Reactive Substances/metabolism , Time Factors
13.
Brain Res ; 818(2): 575-8, 1999 Feb 13.
Article in English | MEDLINE | ID: mdl-10082851

ABSTRACT

Dopaminergic changes were studied in the caudate nucleus of adult female mice after pre- and post-treatment with an antioxidant, selenium, 72 h after the multiple injections of methamphetamine (METH, 4x10 mg/kg, i.p. at 2-h interval) or an equivalent volume of saline. Selenium treatment prevented the depletion of dopamine (DA) and its metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in caudate nucleus resulting from the METH treatment. These data suggest that METH-induced neurotoxicity is mediated by free radical and selenium plays a protective role against METH-induced dopaminergic neurotoxicity.


Subject(s)
Antioxidants/therapeutic use , Dopamine Agents/toxicity , Methamphetamine/toxicity , Neuroprotective Agents/therapeutic use , Selenium/therapeutic use , 3,4-Dihydroxyphenylacetic Acid/metabolism , Animals , Dopamine/metabolism , Female , Homovanillic Acid/metabolism , Methamphetamine/antagonists & inhibitors , Mice , Mice, Inbred C57BL
14.
Arch Biochem Biophys ; 289(1): 161-6, 1991 Aug 15.
Article in English | MEDLINE | ID: mdl-1910313

ABSTRACT

Various inorganic selenocompounds dose-dependently inhibited the rat brain prostaglandin (PG) D synthase, both in the purified enzyme preparation and in the crude brain supernatant. All of the quadrivalent selenium compounds tested had a very limited range of IC50 values in the purified enzyme (11-12 microM) and in the brain supernatant (9-15 microM). A divalent selenium compound was also inhibitory, but a hexavalent selenium compound was ineffective. In contrast, organic selenocompounds such as selenomethionine and selenourea had no effect on the PGD synthase activity. Furthermore, sodium sulfate and sodium sulfite up to 10 mM did not inhibit the activity. The inhibition by selenium required the preincubation of the metal with sulfhydryl compounds such as dithiothreitol (DTT), indicating that the formation of selenotrisulfide or some other adduct(s) is essential for the inhibition. Furthermore, the inhibition was reversed by an excess amount of dithiothreitol, suggesting that the selenotrisulfide derivative of DTT binds to the SH group of the PGD synthase. The kinetic analysis revealed the inhibition by selenite to be noncompetitive with a Ki value of 10.1 microM. On the other hand, glutathione-dependent PGD synthase from rat spleen was much less inhibited, and PGF synthase and PGD2 11-ketoreductase activities were not inhibited by the selenium compound.


Subject(s)
Brain/enzymology , Cyclooxygenase Inhibitors , Organoselenium Compounds , Selenium Compounds , Selenium/pharmacology , Animals , Azoles/pharmacology , Chlorides/pharmacology , Dithiothreitol/pharmacology , Dose-Response Relationship, Drug , Isoindoles , Kinetics , Male , Metals/pharmacology , Rats , Rats, Inbred Strains , Selenious Acid , Sulfur/pharmacology
15.
Exp Pathol ; 29(3): 159-64, 1986.
Article in English | MEDLINE | ID: mdl-3720907

ABSTRACT

The main aim of the present study was to evaluate the neurochemical changes in the levels of gangliosides, total lipids, phospholipids, cholesterol, esterified fatty acids and triglyceride of the hypothalamus, hippocampus, amygdaloid nucleus, midline nuclei of thalamus, gyrus cinguli and olfactory bulbs following the intramuscular administration of ethinylestradiol (100 mcg) to each female rabbit daily for 30 days. Remarkable increment in the concentration of gangliosides was discernible in hippocampus, amygdaloid nucleus and olfactory bulbs. Interestingly, these levels showed significant decrement in the hypothalamus. The contents of total lipids, triglyceride and esterified fatty acids exhibited significant decrease in the hypothalamus. On the other hand, these levels showed a remarkable increment in olfactory bulbs with a significant elevation in the levels of phospholipids. The concentration of phospholipids was, however, markedly depleted in amygdaloid nucleus. The contents of esterified fatty acids exhibited decrement in hippocampus but the midline nuclei of thalamus showed increment. A significant elevation was also discernible in the levels of triglyceride in gyrus cinguli. The results suggest that the lipid contents are affected differentially in the various parts of the brain.


Subject(s)
Brain Chemistry , Brain/metabolism , Estrogens/pharmacology , Gangliosides/isolation & purification , Animals , Brain/drug effects , Cholesterol/analysis , Estrogens/administration & dosage , Fatty Acids/analysis , Female , Gangliosides/analysis , Hippocampus/metabolism , Hypothalamus/metabolism , Injections, Intramuscular , Phospholipids/analysis , Rabbits , Thalamus/metabolism , Tissue Distribution , Triglycerides/analysis
SELECTION OF CITATIONS
SEARCH DETAIL